AMP Horizons Series: Molecular Testing in Thyroid Cancer: Technical Approaches and Clinical Breakthroughs

CME and CMLE credits are not available for this webinar.



Thyroid cancer is the most prevalent endocrine malignancy, and the fifth most common cancer in women. Most cases have an excellent prognosis. However, some patients experience recurrence and develop metastases, while others present with highly aggressive disease, with poor prognosis and limited treatment options. The genomic framework of thyroid cancer has been largely elucidated, and most tumors have well-established genetic drivers. The identification of tumor-specific biomarkers has emerged as a critical diagnostic tool in the evaluation and clinical management of thyroid nodules. Recent FDA-approvals of highly selective kinase inhibitors for the treatment of advanced thyroid cancer underscore the essential role of molecular testing in guiding therapeutic choices. The scientific background, testing considerations, and clinical implications will be addressed in this presentation.


Learning Objectives:

  • Describe the most common genetic alterations associated with the different types of primary thyroid cancer
  • Identify the appropriate assays and platforms for molecular diagnostic testing of thyroid malignancies
  • Discuss the role of genetic testing in the diagnostic assessment and management of thyroid nodules
  • Recognize the clinical utility of molecular diagnostics in guiding systemic therapy selection for advanced disease



Dora Dias-Santagata, PhD, FACMG
Center for Integrated Diagnostics
Massachusetts General Hospit
Honey Reddi, PhD
T&E Committee Genetics Subdivision 
Medical College of Wisconsin

Duration: 1 hr
Level of Instruction: Basic
Date Recorded: January 28, 2021


Planned and coordinated by the Training and Education Committee


Continuing Education Credit Information

CME and CMLE credits are not available for this webinar.



Note: Members of AMP can access this webinar at no cost. Join the AMP Family!


All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.